Zobrazeno 1 - 7
of 7
pro vyhledávání: '"35"'
Autor:
Hsu LJ; Guthrie Research Institute, Laboratory of Molecular Immunology, Sayre, PA, USA.; Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University College of Medicine, Tainan, Taiwan, ROC., Hong Q; Guthrie Research Institute, Laboratory of Molecular Immunology, Sayre, PA, USA., Chen ST; Guthrie Research Institute, Laboratory of Molecular Immunology, Sayre, PA, USA.; Department of Cell Biology and Anatomy, National Cheng Kung University College of Medicine, Tainan, Taiwan, ROC., Kuo HL; Institute of Molecular Medicine, National Cheng Kung University College of Medicine, Tainan, Taiwan, ROC., Schultz L; Guthrie Research Institute, Laboratory of Molecular Immunology, Sayre, PA, USA., Heath J; Guthrie Research Institute, Laboratory of Molecular Immunology, Sayre, PA, USA., Lin SR; Institute of Molecular Medicine, National Cheng Kung University College of Medicine, Tainan, Taiwan, ROC., Lee MH; Institute of Molecular Medicine, National Cheng Kung University College of Medicine, Tainan, Taiwan, ROC., Li DZ; Institute of Molecular Medicine, National Cheng Kung University College of Medicine, Tainan, Taiwan, ROC., Li ZL; Institute of Molecular Medicine, National Cheng Kung University College of Medicine, Tainan, Taiwan, ROC., Cheng HC; Department of Medical Laboratory Science and Biotechnology, National Cheng Kung University College of Medicine, Tainan, Taiwan, ROC., Armand G; Glycomed Research Inc., Hastings on Hudson, New York, NY, USA., Chang NS; Guthrie Research Institute, Laboratory of Molecular Immunology, Sayre, PA, USA.; Institute of Molecular Medicine, National Cheng Kung University College of Medicine, Tainan, Taiwan, ROC.; Advanced Optoelectronic Technology Center, National Cheng Kung University, Tainan, Taiwan, ROC.; Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung, Taiwan, ROC.
Publikováno v:
Oncotarget [Oncotarget] 2017 Mar 21; Vol. 8 (12), pp. 19137-19155.
Autor:
Taylor C; Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Headington, Oxford, OX3 9DS, UK.; Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford, OX3 9DU, UK., Mannion D; Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Headington, Oxford, OX3 9DS, UK.; Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford, OX3 9DU, UK., Miranda F; Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Headington, Oxford, OX3 9DS, UK.; Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford, OX3 9DU, UK., Karaminejadranjbar M; Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Headington, Oxford, OX3 9DS, UK.; Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford, OX3 9DU, UK., Herrero-Gonzalez S; Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Headington, Oxford, OX3 9DS, UK.; Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford, OX3 9DU, UK., Hellner K; Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Headington, Oxford, OX3 9DS, UK.; Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford, OX3 9DU, UK., Zheng Y; Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Headington, Oxford, OX3 9DS, UK.; Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford, OX3 9DU, UK., Bartholomeusz G; Department of Experimental Therapeutics, M.D. Anderson Cancer Center, University of Texas, Houston, TX 77030, USA., Bast RC Jr; Department of Experimental Therapeutics, M.D. Anderson Cancer Center, University of Texas, Houston, TX 77030, USA., Ahmed AA; Ovarian Cancer Cell Laboratory, Weatherall Institute of Molecular Medicine, University of Oxford, Headington, Oxford, OX3 9DS, UK.; Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
Publikováno v:
Oncotarget [Oncotarget] 2017 Mar 14; Vol. 8 (11), pp. 17960-17980.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Andrew D. Badley, Nathan W. Cummins
Publikováno v:
Oncotarget
With 35 million persons estimated to be living with HIV worldwide, and 2 million infections occurring each year, the HIV pandemic remains a significant public health problem. Without an effective vaccine or a cure, control of HIV relies on reliable i
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.